ARCHIVES

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

This article is from The Cancer Letter archive.

Vol. 21 No. 35 | September 15, 1995

Download PDF Visit The Full Archive

Related Articles

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

NIEHS Uses Gene Chips To Evaluate Chemicals.

March 3, 2000

Five Proposals Submitted In Recompetition Of FCRF Operations/Support Contract; Now Under Review

January 2, 1987

NCI-Approved Clinical Trials

January 27, 2006

AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them

May 16, 1975